Testing effectiveness (Phase 2)Study completedNCT01969851
What this trial is testing
Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.
Who this might be right for
Epilepsy
UCB Pharma 55